Literature DB >> 26500991

Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond.

Ankur Sachdeva1, Mona Choudhary2, Mina Chandra3.   

Abstract

Alcohol dependence is an increasing and pervasive problem. Alcohol withdrawal symptoms are a part of alcohol dependence syndrome and are commonly encountered in general hospital settings, in most of the departments. Alcohol withdrawal syndrome ranges from mild to severe. The severe complicated alcohol withdrawal may present with hallucinations, seizures or delirium tremens. Benzodiazepines have the largest and the best evidence base in the treatment of alcohol withdrawal, and are considered the gold standard. Others, such as anticonvulsants, barbiturates, adrenergic drugs, and GABA agonists have been tried and have evidence. Supportive care and use of vitamins is essential in the management. Symptom triggered regime is favoured over fixed tapering dose regime, although monitoring through scales is cumbersome. This article aims to review the evidence base for appropriate clinical management of the alcohol withdrawal syndrome. We searched Pubmed for articles published in English on 'Alcohol withdrawal syndrome' in humans during the last 10 years. A total of 1182 articles came up. Articles not relevant to clinical utility and management were excluded based on the titles and abstract available. Full text articles, meta-analyses, systematic reviews and randomized controlled trials were obtained from this list and were considered for review.

Entities:  

Keywords:  Alcohol detoxification; Management; Pharmacotherapy; Thiamine

Year:  2015        PMID: 26500991      PMCID: PMC4606320          DOI: 10.7860/JCDR/2015/13407.6538

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  68 in total

1.  Rapid suppression of alcohol withdrawal syndrome by baclofen.

Authors:  Giovanni Addolorato; Fabio Caputo; Esmeralda Capristo; Luigi Janiri; Mauro Bernardi; Roberta Agabio; Giancarlo Colombo; Gian Luigi Gessa; Giovanni Gasbarrini
Journal:  Am J Med       Date:  2002-02-15       Impact factor: 4.965

2.  Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal.

Authors:  R Malcolm; J C Ballenger; E T Sturgis; R Anton
Journal:  Am J Psychiatry       Date:  1989-05       Impact factor: 18.112

3.  Residual effects of ethanol and chlordiazepoxide treatments for alcohol withdrawal.

Authors:  F R Funderburk; R P Allen; A M Wagman
Journal:  J Nerv Ment Dis       Date:  1978-03       Impact factor: 2.254

Review 4.  The alcohol withdrawal syndrome.

Authors:  W Hall; D Zador
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

5.  Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome.

Authors:  M Hayashida; A I Alterman; A T McLellan; C P O'Brien; J J Purtill; J R Volpicelli; A H Raphaelson; C P Hall
Journal:  N Engl J Med       Date:  1989-02-09       Impact factor: 91.245

6.  The natural history of alcohol abuse: implications for definitions of alcohol use disorders.

Authors:  D S Hasin; B Grant; J Endicott
Journal:  Am J Psychiatry       Date:  1990-11       Impact factor: 18.112

7.  Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale.

Authors:  J T Sullivan; R M Swift; D C Lewis
Journal:  J Clin Psychopharmacol       Date:  1991-10       Impact factor: 3.153

Review 8.  Ambulatory medical detoxification for alcohol.

Authors:  P J Abbott; D Quinn; L Knox
Journal:  Am J Drug Alcohol Abuse       Date:  1995-11       Impact factor: 3.829

9.  Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey.

Authors:  R C Kessler; C B Nelson; K A McGonagle; J Liu; M Swartz; D G Blazer
Journal:  Br J Psychiatry Suppl       Date:  1996-06

10.  Symptom-triggered versus standard chlormethiazole treatment of inpatient alcohol withdrawal: clinical implications from a chart analysis.

Authors:  Christian Lange-Asschenfeldt; Matthias J Müller; Armin Szegedi; Ion Anghelescu; Christoph Klawe; Hermann Wetzel
Journal:  Eur Addict Res       Date:  2003-01       Impact factor: 3.015

View more
  19 in total

Review 1.  Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development.

Authors:  Colleen A Hanlon; Logan T Dowdle; J Scott Henderson
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 2.  Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

Authors:  Patrycja Kleczkowska; Irena Smaga; Małgorzata Filip; Magdalena Bujalska-Zadrozny
Journal:  Neurotox Res       Date:  2016-08-02       Impact factor: 3.911

Review 3.  Intermittent hypoxia training: Powerful, non-invasive cerebroprotection against ethanol withdrawal excitotoxicity.

Authors:  Marianna E Jung; Robert T Mallet
Journal:  Respir Physiol Neurobiol       Date:  2017-08-12       Impact factor: 1.931

4.  Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital.

Authors:  Nina Vadiei; Tawny L Smith; Amy E Walton; Kimberly L Kjome
Journal:  Psychopharmacol Bull       Date:  2019-02-15

Review 5.  Prevention, screening, and treatment for heavy drinking and alcohol use disorder.

Authors:  Justin Knox; Deborah S Hasin; Farren R R Larson; Henry R Kranzler
Journal:  Lancet Psychiatry       Date:  2019-10-17       Impact factor: 27.083

6.  DNA damage and oxidative stress induced by seizures are decreased by anticonvulsant and neuroprotective effects of lobeline, a candidate to treat alcoholism.

Authors:  Liana Dantas da Costa E Silva; Patrícia Pereira; Gabriela Gregory Regner; Fernanda Brião Menezes Boaretto; Cleonice Hoffmann; Pricila Pflüger; Lucas Lima da Silva; Luiza Reinhardt Steffens; Ana Moira Morás; Dinara Jaqueline Moura; Jaqueline Nascimento Picada
Journal:  Metab Brain Dis       Date:  2017-10-14       Impact factor: 3.584

7.  A Novel Research Method for Determining Sedative Exposure in Critically Ill Patients.

Authors:  Mary Fran Tracy; Linda Chlan; Kay Savik; Debra J Skaar; Craig Weinert
Journal:  Nurs Res       Date:  2019 Jan/Feb       Impact factor: 2.381

8.  Effects of Withdrawal from Chronic Intermittent Ethanol Exposure on Sleep Characteristics of Female and Male Mice.

Authors:  Salvador Huitron-Resendiz; Tali Nadav; Stephanie Krause; Chelsea Cates-Gatto; Ilham Polis; Amanda J Roberts
Journal:  Alcohol Clin Exp Res       Date:  2018-01-30       Impact factor: 3.455

9.  Evaluation of a Web-based Educational Program to Teach the Identification and Management of Alcohol Withdrawal in the Emergency Department.

Authors:  Cameron Thompson; Shelley L McLeod; Vsevolod Perelman; Shirley Lee; Sally Carver; Taylor Dear; Bjug Borgundvaag
Journal:  AEM Educ Train       Date:  2018-11-20

10.  Cortical Glutamate and GABA Changes During Early Abstinence in Alcohol Dependence and Their Associations With Benzodiazepine Medication.

Authors:  Guoying Wang; Wolfgang Weber-Fahr; Ulrich Frischknecht; Derik Hermann; Falk Kiefer; Gabriele Ende; Markus Sack
Journal:  Front Psychiatry       Date:  2021-07-05       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.